文献速递衰弱、肌少症与跌倒认知障碍与谵妄多重用药

衰弱老年患者使用低剂量氟哌啶醇是否仍需监测QTc?前瞻性观察队列研究

Should we still monitor QTc duration in frail older patients on low-dose haloperidol? A prospective observational cohort study.
PubMed 文献 · Age Ageing · 2020-01-01

该前瞻性观察队列研究纳入150例接受氟哌啶醇的≥70岁衰弱住院谵妄患者及150例年龄和衰弱匹配的对照,比较入院及住院期间系列心电图QTc变化。结果显示基线QTc边缘或异常者QTc缩短,两组趋势相似,无患者出现危险QTc,提示低剂量氟哌啶醇或无需常规心电监测。

要点

  • 低剂量氟哌啶醇组平均每24小时1.5 mg,无患者出现危险QTc。
  • 基线QTc边缘或异常者QTc缩短,对照组也呈相似缩短趋势。
  • 衰弱老年谵妄患者使用低剂量氟哌啶醇时心电监测可能并非必要。

核心结论

  • 低剂量氟哌啶醇组观察到QTc缩短趋势,尤其基线QTc边缘或异常者,且与是否使用氟哌啶醇无关。
  • 研究提示衰弱老年患者接受低剂量氟哌啶醇时,心电监测可能并非必要。

研究设计与样本

  • 前瞻性观察性队列研究,纳入≥70岁且Groningen衰弱指数评分>3的住院患者。
  • 氟哌啶醇组150例,年龄和衰弱匹配的对照组150例,入院及住院期间行系列心电图。

主要发现

  • 氟哌啶醇组平均年龄85岁,48%男性,平均每24小时剂量1.5 mg。
  • 氟哌啶醇组基线QTc边缘者平均变化-15±29 ms(P<0.05),异常者-19±27 ms(P<0.05)。
  • 对照组基线QTc边缘者平均变化-7±16 ms,异常者-23±20 ms。
  • 无患者出现危险QTc,定义为QTc>500 ms或增加>50 ms。

关键数值与推荐

  • 危险QTc定义为QTc>500 ms或较基线增加>50 ms。
  • QT间期按Framingham公式校正为QTc,根据基线QTc分为正常、边缘或异常组。

临床怎么用

  • 对于接受低剂量氟哌啶醇的衰弱老年谵妄患者,可考虑不将常规心电监测作为必需措施。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Haloperidol at high dosage is associated with QTc prolongation and polymorphic ventricular arrhythmia but the effects of low-dose haloperidol remain unknown. OBJECTIVE: To evaluate the effects of low-dose haloperidol on QTc-duration in frail hospitalized elderly patients with delirium. METHODS: A prospective observational study including hospitalized patients aged ≥70 years with Groningen Frailty Index-score > 3. We included 150 patients who received haloperidol and 150 age- and frailty-matched control patients. Serial ECG recordings were performed at hospital admission and during hospitalization. QT-interval was corrected according to Framingham (QTc). Patients were grouped according to baseline QTc in normal (nQTc), borderline (bQTc) or abnormal (aQTc). Primary outcome was change in QTc-duration between first and second ECG. Potentially dangerous QTc was defined as QTc >500 ms or an increase of >50 ms. RESULTS: Patients in the haloperidol group (48% male, mean age 85y, nQT n = 98, bQT n = 31, aQT n = 20) received an average dose of 1.5 mg haloperidol per 24 hours. QTc decreased in patients with borderline (mean - 15 ± 29 ms, P < 0.05) or abnormal (-19 ± 27 ms, P < 0.05) QTc at baseline, no patients developed dangerous QTc-duration. In the control group (41% male, mean age 84y, nQT n = 99 bQT n = 29, aQT n = 22) QTc decreased to a similar extent (bQT -7 ± 16 ms, aQTc -23 ± 20 ms). CONCLUSION: A trend to QTc shortening was seen, especially in patients with borderline or abnormal QTc at baseline, regardless of haloperidol use. These findings suggest that ECG monitoring of frail elderly patients who receive low-dose haloperidol, may not be necessary.

来源:Age Ageing,查看原文。版权归原作者所有。

引用

  1. Castro E, Körver F, Merry A, et al. Should we still monitor QTc duration in frail older patients on low-dose haloperidol? A prospective observational cohort study. Age Ageing. 2020. PMID: 32614955. doi:10.1093/ageing/afaa066

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。